THE EVALUATION OF QUALITY OF IMMUNIZATION SERVICES OF CHILDREN IN PRIMARY MEDICAL SANITARY CENTERS IN ORON, AKWA IBOM STATE, NIGERIA
- Authors: Esu D.J.1, Kicha D.I.1
- Affiliations:
- The Federal State Autonomous Educational Institution of Higher Education “The Patrice Lumumba Peoples' Friendship University of Russia” of Minobrnauka of Russia (RUDN University), 117198, Moscow, Russia
- Issue: Vol 31, No 5 (2023)
- Pages: 1021-1027
- Section: Articles
- URL: https://journal-nriph.ru/journal/article/view/2134
- DOI: https://doi.org/10.32687/0869-866X-2023-31-5-1021-1027
- Cite item
Abstract
Nigeria, with its low routine immunization coverage and wild poliovirus reservoir, significantly contributes to overall regional burden of vaccine preventable diseases. Since introduction of the EPI in 1974 (which later became the National Program of Immunization), Nigeria’s immunization program suffered from declining coverage. The poor quality of immunization affects service utilization, even where they are provided for free, just as immunization services are. The quality assessment will provide both notion of degree of satisfaction of clients with services and framework for revision of program priorities, strategies and components Purpose of the study is to evaluate quality of immunization services provided to children in primary health centers in Oron, Akwa Ibom State, Nigeria. The study targets to identify strengths and weaknesses of immunization services, to evaluate level of compliance with national and international standards of immunization and to develop corresponding recommendations. The study seeks to contribute to body of knowledge about quality of children immunization services in Nigeria, particularly in context of primary health centers. The study may help to improve delivery of immunization services in the region and to ensure that more children will be vaccinated and protected against vaccine preventable diseases.
About the authors
David John Esu
The Federal State Autonomous Educational Institution of Higher Education “The Patrice Lumumba Peoples' Friendship University of Russia” of Minobrnauka of Russia (RUDN University), 117198, Moscow, Russia
D. I. Kicha
The Federal State Autonomous Educational Institution of Higher Education “The Patrice Lumumba Peoples' Friendship University of Russia” of Minobrnauka of Russia (RUDN University), 117198, Moscow, Russia
References
- Perin J., Mulick A., Yeung D., Villavicencio F., Lopez G., Strong K. L., Prieto-Merino D., Cousens S., Black R. E., Liu L. Global, regional, and national causes of under-5 mortality in 2000—19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child. Adolesc. Health. 2022;6(2):106—15. doi: 10.1016/S2352-4642(21)00311-4
- Dunavan C. P. Are We Truly Winning the War Against Malnutrition? Am. J. Trop. Med. Hyg. 2022 Mar 14;106(5):1561—4. doi: 10.4269/ajtmh.22-0006. Epub ahead of print.
- Scarinci I. C., Hansen B., Kim Y. I. HPV vaccine uptake among daughters of Latinx immigrant mothers: Findings from a cluster randomized controlled trial of a community-based, culturally relevant intervention. Vaccine. 2020;38(25):4125—34. doi: 10.1016/j.vaccine.2020.03.052. Epub 2020 Apr 27.
- Perry H. B. An extension of the Alma-Ata vision for primary health care in light of twenty-first-century evidence and realities. Gates Open Res. 2018 Dec 14;2:70. doi: 10.12688/gatesopenres.12848.1
- Badur S., Ota M., Öztürk S., Adegbola R., Dutta A. Vaccine confidence: the keys to restoring trust. Hum. Vaccin. Immunother. 2020 May 3;16(5):1007—17. doi: 10.1080/21645515.2020.1740559
- Anderson J. D. 4th, Bagamian K. H., Muhib F., Baral R., Laytner L. A., Amaya M., Wierzba T., Rheingans R. Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries. Vaccine X. 2019 Apr 18;2:100024. doi: 10.1016/j.jvacx.2019.100024
- Wahl B., O'Brien K. L., Greenbaum A., Majumder A., Liu L., Chu Y., Lukšić I., Nair H., McAllister D. A., Campbell H., Rudan I., Black R., Knoll M. D. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000—15. Lancet Glob. Health. 2018 Jul;6(7):e744—e757. doi: 10.1016/S2214-109X(18)30247-X
- Ibrahim B. S., Usman R., Mohammed Y., Datti Z., Okunromade O., Abubakar A. A., Nguku P. M. The burden of measles in Nigeria: a five-year review of case-based surveillance data, 2012—2016. Pan Afr. Med. J. 2019 Jan 22;32(Suppl 1):5. doi: 10.11604/pam.supp.2019.32.1.13564
- Périères L., Séror V., Boyer S., Sokhna C., Peretti-Watel P. Reasons given for non-vaccination and under-vaccination of children and adolescents in sub-Saharan Africa: A systematic review. Hum. Vaccin. Immunother. 2022 Nov 30;18(5):2076524. doi: 10.1080/21645515.2022.2076524
- Atkinson M. K., Schuster M. A., Feng J. Y., Akinola T., Clark K. L., Sommers B. D. Adverse Events and Patient Outcomes Among Hospitalized Children Cared for by General Pediatricians vs Hospitalists. JAMA Netw. Open. 2018;1(8):e185658. doi: 10.1001/jamanetworkopen.2018.5658
- Palumbo R., Annarumma C., Manna R., Musella M., Adinolfi P. Improving quality by involving patient. The role of health literacy in influencing patients’ behaviors. Int. J. Healthcare Manag. 2021;14(1):144—52. doi: 10.1080/20479700.2019.1620458
- Ochie C. N., Aniwada E. C., Uchegbu E. K., Asogwa T. C., Onwasoigwe C. N. Infection prevention and control: knowledge, determinants and compliance among primary healthcare workers in Enugu metropolis, south-east Nigeria. Infect. Prev. Pract. 2022 Apr 27;4(2):100214. doi: 10.1016/j.infpip.2022.100214
- Kalkowska D. A., Franka R., Higgins J., Kovacs S. D., Forbi J. C., Wassilak S. G. F., Pallansch M. A., Thompson K. M. Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria. Risk Analysis. 2021;41:289—302. doi: 10.1111/risa.13485
- Li A. J., Manzi F., Kyesi F., Makame Y., Mwengee W., Fleming M., Mkopi A., Mmbaga S., Lyimo D., Loharikar A. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019. Vaccine. 2022 Mar 31;40 Suppl 1(Suppl 1):A38—A48. doi: 10.1016/j.vaccine.2021.06.047